RUA Life Sciences (AIM:RUA), the holding company of a group of medical device businesses focused on the exploitation of the world's leading long-term implantable biostable polymer (Elast-EonTM), will be conducting an Investor Presentation covering their FY results for the year ended 31st March 2022.
The event will take place at 2.00pm on Monday 18th July with Bill Brown (Chairman) and Caroline Stretton (CEO) presenting from the company.
The online presentation is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.
